Vision for Europe:
Innovation, Investment, Excellence

The European Union continues to grow as a region of healthcare biotech excellence. Creating an environment to attract, maintain, and grow investments in innovative healthcare biotech discoveries will ensure that the EU is the world’s most advanced region for both public and private biotech research and development.

EuropaBio’s vision: A Europe where biotechnology delivers benefits across society, from high-skill jobs and economic strength to ground-breaking treatments that change and save lives.

We are joining forces with innovators, policy-makers and other key actors in biotechnology to deliver on this vision for Europe.

Together, we will revolutionise the future of healthcare.

Read more

Knowledge hub

Browse our knowledge hub – featuring EuropaBio and member reports, white papers, case studies, publications, consultation responses and infographics that provide insight on a range of topics related to healthcare innovation, investment and excellence in Europe.

11/11/2022
The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?
20/10/2022
Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe
11/10/2022
Factsheet – Vision for Europe: Excellence
11/10/2022
Factsheet – Vision for Europe: Investment
11/10/2022
Factsheet – Vision for Europe: Innovation
06/10/2022
EuropaBio celebrates its inaugural Healthcare BioForum
03/10/2022
Vision for Europe: Innovation, Investment, Excellence | Claire Skentelbery, EuropaBio
21/09/2022
Vision for Europe:Innovation, Investment, Excellence | Yordan Aleksandrov, Pfizer

Europe has the potential to become the world’s most innovative biotech region by creating the right environment to attract investments and excellence

The EU needs to make sure that our single market works for innovation.

New medicines don’t fall from trees – they require the right eco-system and careful nurturing! Europe is the richest continent in the world with the highest skills level and the best innovators. Let’s live up to that reality when it comes to protecting and promoting innovation!

David EARNSHAW,

Board member of EuropaBio representing MSD Europe Inc.

Research and development is not an engine you can simply turn off and on.

It's an interdependent ecosystem requiring nurture and care in order to create the right environment for innovation to flourish. In order to serve the patient’s needs, the EU needs a strong Intellectual Property framework to recognise the significant investments in the treatments of tomorrow.

Andrew TOPEN,

Chair of EuropaBio representing Novartis

The EU has the potential to become the world’s most innovative biotech region.

With that in mind EuropaBio welcomes the EC’s intention of supporting “a competitive and innovative European pharmaceutical environment” (as stated in the EC’s 2020 Pharmaceutical Strategy for Europe). To realise this goal the EU must address the factors that are causing Europe to fall behind, such as creating a world class regulatory framework and an environment that incentivises and rewards innovation. A successful pharmaceutical sector in the EU not only has the prospect of improving public health and saving lives but can also create jobs and wealth for our economy.

Neil MULCOCK,

Chair of EuropaBio Healthcare Biotechnology council representing Gilead

The EU needs to continue to strengthen opportunities.

The EU has the potential to become the world’s most innovative biotech region by creating the right environment to attract investments and excellence. To do so, the EU needs to continue to strengthen opportunities for meaningful patient-centric, value-based partnerships. By leveraging shared innovation, ideas and investments, we (the pharma industry) can drive greater impact for patients across the region.

Ms. Luana BANU,

EuropaBio Board member, representing Takeda

 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe